Cliff Asness's DAWN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 444,467 shares of Day One Biopharmaceuticals, Inc. (DAWN) worth $9.53 M, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in DAWN, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 530,429 shares. Largest reduction occurred in Q2 2025, reducing 338,777 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Day One Biopharmaceuticals (DAWN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Day One Biopharmaceuticals (DAWN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +12,709 | Add 2.94% | 444,467 | $21.44 |
| Q4 2025 | +323,281 | Add 298.02% | 431,758 | $9.32 |
| Q3 2025 | -171,373 | Reduce 61.24% | 108,477 | $7.05 |
| Q2 2025 | -338,777 | Reduce 54.76% | 279,850 | $6.50 |
| Q1 2025 | +530,429 | Add 601.41% | 618,627 | $7.93 |
| Q4 2024 | -42,112 | Reduce 32.32% | 88,198 | $12.67 |
| Q3 2024 | +17,290 | Add 15.30% | 130,310 | $13.93 |
| Q2 2024 | +94,703 | Add 517.02% | 113,020 | $13.78 |
| Q1 2024 | +8,159 | Add 80.32% | 18,317 | $16.52 |
| Q4 2023 | +10,158 | New Buy | 10,158 | $14.60 |
| Q3 2023 | -14,404 | Sold Out | 0 | $0.00 |
| Q2 2023 | +1,348 | Add 10.32% | 14,404 | $11.94 |
| Q1 2023 | +3,545 | Add 37.27% | 13,056 | $13.37 |
| Q4 2022 | +9,511 | New Buy | 9,511 | $21.52 |
Cliff Asness's Day One Biopharmaceuticals Investment FAQs
Cliff Asness first purchased Day One Biopharmaceuticals, Inc. (DAWN) in Q4 2022, acquiring 9,511 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Day One Biopharmaceuticals, Inc. (DAWN) for 14 quarters since Q4 2022.
Cliff Asness's largest addition to Day One Biopharmaceuticals, Inc. (DAWN) was in Q1 2025, adding 618,627 shares worth $4.91 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 444,467 shares of Day One Biopharmaceuticals, Inc. (DAWN), valued at approximately $9.53 M.
As of the Q1 2026 filing, Day One Biopharmaceuticals, Inc. (DAWN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Day One Biopharmaceuticals, Inc. (DAWN) was 618,627 shares, as reported at the end of Q1 2025.